Dewpoint Therapeutics
Phi is a Texas native where he received a BS in microbiology from UT Austin in 2006. He completed his PhD in biochemistry at UT Southwestern investigating the structure and kinetic mechanisms of AMPylator enzymes. Phi’s postdoctoral research at Boston Children’s contributed to mechanistic and chemogenomic efforts in the field of biomolecular condensates, inflammatory bowel disease and the biological networks of intracellular trafficking. At Dewpoint he is continuing his interests in condensate biology to help uncover its mysteries and develop treatments to improve human lives.